The medical community is taking steps to clarify delirium pathology and diagnosis.

Robotics, stem cell therapy, and computer-controlled interfaces are promising, but cost may slow adoption.

Adopting a more open-access environment crucial to developing new technologies for understanding the human brain.

Cerebrospinal fluid, neuroimaging techniques, and blood and skin peripheral tissues may hold the answers to recognizing Alzheimer’s disease earlier.

Advanced imaging technologies to monitor multiple sclerosis (MS) are being developed but have been plagued by high costs and invasive procedures.

The broad pathology of sleep disorders can make diagnosis and treatment complicated.

Diagnosis of rapidly progressive dementias is difficult due to broad pathology and underdeveloped diagnostic criteria for clinical settings.

Several anti-diabetes agents hold promise for Parkinson’s disease-related neurodegeneration.

If the UTHealth mobile stroke unit program can show that treating ischemic stroke within 60 minutes is feasible and cost effective, more may start rolling out nationally.

Attention-deficit hyperactivity-disorder (ADHD) is one of the most common neurobehavioral childhood disorders, according to the CDC. American Psychiatric Association data reveal that between 3% and 7% of U.S. school age children have some form of ADHD as defined by the Diagnostic and Statistical Manual of Mental Disorders criteria, and that prevalence has been increasing in…